So far this year, we have witnessed how companies have adapted to the new normal of the pandemic lifestyle to drive business.
Boomer Naturals: Hitting the bull’s eye during the pandemic
Categories
Health Care
Rite Aid’s (RAD) loss narrows in Q2 2021
Rite Aid Corporation (NYSE: RAD) reported a narrower loss in the second quarter of 2021. Net loss shrank to $0.25 per share
Centogene N.V. (CNTG) Q2 2020 Earnings Call Transcript
Centogene N.V. (NASDAQ: CNTG) Q2 2020 earnings call dated Sep. 23, 2020 Corporate Participants: Sun Kim -- Chief Strategy and Investor Relations Officer Prof.
Acutus Medical, Inc (AFIB) Q2 2020 Earnings Call Transcript
Acutus Medical, Inc (NASDAQ: AFIB) Q2 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Caroline Corner -- Investor Relations, Westwicke ICR Vince Burgess -- President
Oak Street Health, Inc. (OSH) Q2 2020 Earnings Call Transcript
Oak Street Health, Inc. (NYSE: OSH) Q2 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Mike Pykosz -- Chief Executive Officer and Chairman
BeyondSpring Inc. (BYSI) Q2 2020 Earnings Call Transcript
BeyondSpring Inc. (NASDAQ: BYSI) Q2 2020 earnings call dated Sep. 03, 2020 Corporate Participants: Scott Eckstein -- Vice President Lan Huang -- Co-Founder, Chairman & Chief
Aurora Cannabis Inc. (ACB) Q4 2020 Earnings Call Transcript
Aurora Cannabis Inc (NYSE: ACB) Q4 2020 earnings call dated Sep. 22, 2020 Corporate Participants: Miguel Martin -- Chief Executive Officer and Chief Commercial
Neogen Corp. (NEOG) Q1 2021 Earnings Call Transcript
Neogen Corp (NASDAQ: NEOG) Q1 2021 earnings call dated Sep. 22, 2020 Corporate participants: John Adent -- Chief Executive Officer and President Steve Quinlan -- Chief
ERYTECH Pharma S.A. (ERYP) Q2 2020 Earnings Call Transcript
ERYTECH Pharma S.A. (NASDAQ: ERYP) Q2 2020 earnings call dated Sep. 22, 2020 Corporate Participants: Gil Beyen -- Chief Executive Officer Eric Soyer -- Chief Financial
Catalent Inc (CTLT) Q4 2020 Earnings Call Transcript
Catalent Inc (NYSE: CTLT) Q4 2020 Earnings Call dated Aug. 31, 2020 Corporate Participants: Paul Surdez -- Vice President, Investor Relations John
Moderna (MRNA) set to take advantage of opportunity in vaccines
Shares of Moderna Inc. (NASDAQ: MRNA) have gained 246% since the beginning of this year and more than 279% over the past
Patterson Companies Inc. (PDCO) Q1 2021 Earnings Call Transcript
Patterson Companies Inc. (NASDAQ: PDCO) Q1 2021 earnings call dated Sep. 03, 2020 Corporate Participants: John M. Wright -- Vice President of Investor Relations
Illumina (ILMN) is uniquely placed to offer long-term returns. Here’s why
Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare sector through
IsoRay Inc. (ISR) Q4 2020 Earnings Call Transcript
IsoRay Inc (NYSEAMERICAN : ISR) Q4 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Mark Levin -- Investor Relations Lori A. Woods -- Chief Executive
Veritas Farms Inc. (VFRM) Q4 2020 Earnings Call Transcript
Veritas Farms Inc. (OTCMKTS : VFRM) Q4 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Derek Thomas -- Vice President Of Business Development
Cantel Medical Corp. (NYSE: CMD) Q4 2020 Earnings Call Transcript
Cantel Medical Corp. (NYSE: CMD) Q4 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Matthew C. Micowski -- Vice President, Financial Planning &
Humana (HUM) can offer long-term returns despite high valuation
https://www.youtube.com/watch?v=zOVB6xD8rS4 There has been a marked decrese in the number of people seeking healthcare services since the virus outbreak but most healthcare
COVID-19 vaccine development: A look at some of the pharma companies and their progress
The COVID-19 pandemic continues to go on and while the world is slowly coming out of the previously imposed strict lockdown, things
Silence Therapeutics PLC (SLN) Q2 2020 Earnings Call Transcript
Silence Therapeutics PLC (LON: SLN) Q2 2020 earnings call dated Sep. 14, 2020 Corporate Participants: Gem Hopkins -- Head of Investor Relations and Corporate
NovoCure (NVCR): Why this medtech firm matters
Even as COVID-19 is wreaking havoc across the world, cancer continues to kill about 10 million people per year, and the quest
NovoCure Limited (NVCR) Q2 2020 Earnings Call Transcript
NovoCure Limited (NASDAQ: NVCR) Q2 2020 earnings call dated Jul. 30, 2020 https://www.youtube.com/watch?v=f1kpNPlyXaE&t=455s Corporate Participants: Ashley Cordova -- Senior Vice President of Finance &